Lilly targets India as global export hub amid booming Mounjaro sales, executive says

Eli Lilly aims to make India a global supply chain hub, investing $1 billion in contract manufacturing as Mounjaro becomes India’s top-selling drug. Expansion includes donanemab and orforglipron.​Read More